| Features | |
| Active substance | Cabergolina |
| Also known as | Cabaser |
| Blood pressure | May cause hypotension |
| Chemical name | Cabergoline |
| Dosage (medical) | Typically 0.5 mg per week, may vary based on condition |
| Dosage (sports) | Not specified or recommended for sports use |
| Effects | Reduces prolactin levels, may help treat symptoms associated with hyperprolactinemia |
| Formula | C26H37N5O2 |
| Half-life | 63 to 69 hours |
| Hepatotoxicity | Low risk, but liver function tests are recommended |
| Lab Test | Prolactin levels, liver function tests |
| Main action | Inhibition of prolactin secretion |
| Side effects | Nausea, headache, dizziness, orthostatic hypotension |
| Storage conditions | Store at room temperature, protect from light and moisture |
| Substance class | Ergoline derivative, Dopamine D2 receptor agonist |
| Trade name | Dostinex |
| Use in sports | Not officially sanctioned, possibly used to control side effects of anabolic steroids |
| Water Retention | No |
| Active ingredient, mg | 0,5 |
| Release form | Pills |
| 1 Pill, mg | 0,5 |
| Manufacturer | Pfizer Labs |
| Packing | 1 pill, Packing (8 Pills) |